COVID-19: Vaccines and Therapeutics
With mask restrictions lifting as a new omicron variant emerges, an Allina Health infectious disease expert takes to the airwaves, encouraging people to get a first or second COVID-19 vaccine booster.
Amid new variants and lifted restrictions, an Allina Health infectious disease expert encourages…
The trial included 140 children who received the booster about 6 months after completing the primary vaccine series.
In a study of adults previously infected with COVID-19, the Pfizer and Moderna COVID-19 vaccines offered additional protection against reinfection leading to hospitalization.
The agency last week extended the J&J vaccine's shelf life and authorized two COVID-19 tests.
Experts from Duke Health explain how the COVID-19 vaccine is moving the nation toward endemicity.
The Centers for Medicare & Medicaid Services today released a memorandum and provider-specific guidance on complying with the interim final rule.
Medicare and Medicaid will cover a second Pfizer or Moderna COVID-19 booster at no cost to eligible enrollees.
HHS has stopped distributing the monoclonal antibody sotrovimab because the BA.2 omicron variant now predominates in every U.S. state and territory.
AHA has a new toolkit that hospitals and health systems can use in their communities to encourage vaccinations against influenza and COVID-19.
The Centers for Medicare & Medicaid Services (CMS) today released updated guidance for compliance with the agency’s COVID-19 vaccination requirement for health care staff.